» Articles » PMID: 3194846

An Expanded View of Risk-group Definition in Differentiated Thyroid Carcinoma

Overview
Journal Surgery
Specialty General Surgery
Date 1988 Dec 1
PMID 3194846
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

There continues to be controversy about every aspect of management of differentiated thyroid carcinoma. In an age-based risk group previously described, low-risk patients made up 62% of cases and had a death rate of only 1%. Recent reports from the Mayo Clinic have expanded the concept of the low-risk group to include 86% of all cases with a 2% death rate by utilizing several anatomic and pathologic criteria of risk. We offer here another multifactorial system for the identification of low-risk patients who made up 89.4% of all patient seen between 1961 and 1980 and who have a death rate of only 1.8%. The resultant high-risk group constitutes 11% of cases but carries a 46% mortality rate. The risk-group definition is completely clinical and is based on age, presence of distant metastases, and the size and extent of primary cancer. It can be used confidently at the operating table to select conservative surgical procedures in patients with negligible risk of death. Through the succeeding decades analyzed, from 1941 to 1980, the effectiveness of this clinical categorization has increased substantially in separating patients at high and low risk, so that a mortality rate ratio of 26:1 now exists between high- and low-risk groups, respectively.

Citing Articles

Age-stratified deep learning model for thyroid tumor classification: a multicenter diagnostic study.

Zou W, Zhou Y, Yao J, Feng B, Xiong D, Chen C Eur Radiol. 2025; .

PMID: 39903238 DOI: 10.1007/s00330-025-11386-7.


Analysis of the ideal cutoff age as a predictor of differentiated thyroid cancer using the Surveillance, Epidemiology, and End Results database.

Peng H, Zheng M, Li J, Jin Z Transl Cancer Res. 2024; 13(8):4278-4289.

PMID: 39262486 PMC: 11384314. DOI: 10.21037/tcr-24-247.


Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.

Ito Y, Miyauchi A Eur Thyroid J. 2024; 13(5).

PMID: 39213599 PMC: 11466271. DOI: 10.1530/ETJ-24-0196.


Interstitial Fibrosis as a Common Counterpart of Histopathological Risk Factors in Papillary Thyroid Microcarcinoma: A Retrospective Analysis.

Sahin C, Inan M, Bilezikci B, Bostanci H, Taneri F, Kozan R Diagnostics (Basel). 2024; 14(15).

PMID: 39125500 PMC: 11311513. DOI: 10.3390/diagnostics14151624.


Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma ≤1.5 cm in preoperative ultrasonography: MASTER study.

Ju S, Ji Y, Song M, Lim J, Heo D, Kim M Eur Thyroid J. 2024; 13(2).

PMID: 38484463 PMC: 11046321. DOI: 10.1530/ETJ-23-0258.